2016
DOI: 10.1016/j.jaci.2015.08.043
|View full text |Cite
|
Sign up to set email alerts
|

Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway

Abstract: Blood fibrocytes are recruited during COPD exacerbations and related to mortality and low lung function. The CXCL12/CXCR4 axis is involved in such fibrocyte recruitment (Firebrob study; ClinicalTrials NCT01196832).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

7
62
1

Year Published

2017
2017
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 60 publications
(70 citation statements)
references
References 27 publications
7
62
1
Order By: Relevance
“…We found an increased frequency of circulating fibrocytes (identified as CD45+Col1+ cells) in patients with active, untreated CP compared with healthy controls, although we could not demonstrate correlations or associations with disease‐related parameters (e.g., acute‐phase reactants), clinical manifestations, or specific disease phenotypes such as IgG4‐related cases. The peripheral fibrocyte concentrations observed in our study subjects are in the range of those reported in other conditions, although the results are often difficult to compare due to heterogeneous staining or isolation techniques . Notably, we also detected significant amounts of fibrocytes in biopsy samples from CP patients, where such cells were identified not only on the basis of their dual positivity for CD45 and proCol1 but also as proCol1+ cells coexpressing CXCR4, the receptor of CXCL12/SDF‐1, a chemokine that regulates fibrocyte homing .…”
Section: Discussionsupporting
confidence: 55%
“…We found an increased frequency of circulating fibrocytes (identified as CD45+Col1+ cells) in patients with active, untreated CP compared with healthy controls, although we could not demonstrate correlations or associations with disease‐related parameters (e.g., acute‐phase reactants), clinical manifestations, or specific disease phenotypes such as IgG4‐related cases. The peripheral fibrocyte concentrations observed in our study subjects are in the range of those reported in other conditions, although the results are often difficult to compare due to heterogeneous staining or isolation techniques . Notably, we also detected significant amounts of fibrocytes in biopsy samples from CP patients, where such cells were identified not only on the basis of their dual positivity for CD45 and proCol1 but also as proCol1+ cells coexpressing CXCR4, the receptor of CXCL12/SDF‐1, a chemokine that regulates fibrocyte homing .…”
Section: Discussionsupporting
confidence: 55%
“…[22,23] Here, we confirmed that a major proportion of human fibrocytes (nearly 80%) in the peripheral blood of NEC patients expressed CXCR4. At the same time, the CXCR4 receptors were present at a high level in the serum samples from NEC patients, which was similar to observations in patients with fibrotic lung disease.…”
Section: Discussionsupporting
confidence: 74%
“…To our knowledge, the later finding regarding COPD has not been previously described. Further studies are needed to confirm the underlying mechanisms of this association, but it can be hypothesized that pathological remodeling processes, as, for example, TGF-β signaling pathways or circulating fibroblasts, associated with ILD/IPF (34, 35) or COPD (3639), may persist or be activated in some patients after LT and thus contribute to the higher risk of RAS.…”
Section: Discussionmentioning
confidence: 99%